Untapped potential of observational research to inform clinical decision making: American Society of Clinical Oncology Research statement

Kala Visvanathan, Laura A. Levit, Derek Raghavan, Clifford A. Hudis, Sandra Wong, Amylou Dueck, Gary H. Lyman

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

ASCO believes that high-quality observational studies can advance evidence-based practice for cancer care and are complementary to randomized controlled trials (RCTs). Observational studies can generate hypotheses by evaluating novel exposures or biomarkers and by revealing patterns of care and relationships that might not otherwise be discovered. Researchers can then test these hypotheses in RCTs. Observational studies can also answer or inform questions that either have not been or cannot be answered by RCTs. In addition, observational studies can be used for postmarketing surveillance of new cancer treatments, particularly in vulnerable populations. The incorporation of observational research as part of clinical decision making is consistent with the position of many leading institutions. ASCO identified five overarching recommendations to enhance the role of observational research in clinical decision making: (1) improve the quality of electronic health data available for research, (2) improve interoperability and the exchange of electronic health information, (3) ensure the use of rigorous observational research methodologies, (4) promote transparent reporting of observational research studies, and (5) protect patient privacy.

Original languageEnglish (US)
Pages (from-to)1845-1854
Number of pages10
JournalJournal of Clinical Oncology
Volume35
Issue number16
DOIs
StatePublished - Jun 1 2017

Fingerprint

Observational Studies
Research
Randomized Controlled Trials
Privacy
Evidence-Based Practice
Vulnerable Populations
Neoplasms
Research Design
Biomarkers
Research Personnel
Clinical Decision-Making
Health
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Untapped potential of observational research to inform clinical decision making : American Society of Clinical Oncology Research statement. / Visvanathan, Kala; Levit, Laura A.; Raghavan, Derek; Hudis, Clifford A.; Wong, Sandra; Dueck, Amylou; Lyman, Gary H.

In: Journal of Clinical Oncology, Vol. 35, No. 16, 01.06.2017, p. 1845-1854.

Research output: Contribution to journalArticle

Visvanathan, Kala ; Levit, Laura A. ; Raghavan, Derek ; Hudis, Clifford A. ; Wong, Sandra ; Dueck, Amylou ; Lyman, Gary H. / Untapped potential of observational research to inform clinical decision making : American Society of Clinical Oncology Research statement. In: Journal of Clinical Oncology. 2017 ; Vol. 35, No. 16. pp. 1845-1854.
@article{c63f066ce19d414e9eed5960318a0d75,
title = "Untapped potential of observational research to inform clinical decision making: American Society of Clinical Oncology Research statement",
abstract = "ASCO believes that high-quality observational studies can advance evidence-based practice for cancer care and are complementary to randomized controlled trials (RCTs). Observational studies can generate hypotheses by evaluating novel exposures or biomarkers and by revealing patterns of care and relationships that might not otherwise be discovered. Researchers can then test these hypotheses in RCTs. Observational studies can also answer or inform questions that either have not been or cannot be answered by RCTs. In addition, observational studies can be used for postmarketing surveillance of new cancer treatments, particularly in vulnerable populations. The incorporation of observational research as part of clinical decision making is consistent with the position of many leading institutions. ASCO identified five overarching recommendations to enhance the role of observational research in clinical decision making: (1) improve the quality of electronic health data available for research, (2) improve interoperability and the exchange of electronic health information, (3) ensure the use of rigorous observational research methodologies, (4) promote transparent reporting of observational research studies, and (5) protect patient privacy.",
author = "Kala Visvanathan and Levit, {Laura A.} and Derek Raghavan and Hudis, {Clifford A.} and Sandra Wong and Amylou Dueck and Lyman, {Gary H.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1200/JCO.2017.72.6414",
language = "English (US)",
volume = "35",
pages = "1845--1854",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "16",

}

TY - JOUR

T1 - Untapped potential of observational research to inform clinical decision making

T2 - American Society of Clinical Oncology Research statement

AU - Visvanathan, Kala

AU - Levit, Laura A.

AU - Raghavan, Derek

AU - Hudis, Clifford A.

AU - Wong, Sandra

AU - Dueck, Amylou

AU - Lyman, Gary H.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - ASCO believes that high-quality observational studies can advance evidence-based practice for cancer care and are complementary to randomized controlled trials (RCTs). Observational studies can generate hypotheses by evaluating novel exposures or biomarkers and by revealing patterns of care and relationships that might not otherwise be discovered. Researchers can then test these hypotheses in RCTs. Observational studies can also answer or inform questions that either have not been or cannot be answered by RCTs. In addition, observational studies can be used for postmarketing surveillance of new cancer treatments, particularly in vulnerable populations. The incorporation of observational research as part of clinical decision making is consistent with the position of many leading institutions. ASCO identified five overarching recommendations to enhance the role of observational research in clinical decision making: (1) improve the quality of electronic health data available for research, (2) improve interoperability and the exchange of electronic health information, (3) ensure the use of rigorous observational research methodologies, (4) promote transparent reporting of observational research studies, and (5) protect patient privacy.

AB - ASCO believes that high-quality observational studies can advance evidence-based practice for cancer care and are complementary to randomized controlled trials (RCTs). Observational studies can generate hypotheses by evaluating novel exposures or biomarkers and by revealing patterns of care and relationships that might not otherwise be discovered. Researchers can then test these hypotheses in RCTs. Observational studies can also answer or inform questions that either have not been or cannot be answered by RCTs. In addition, observational studies can be used for postmarketing surveillance of new cancer treatments, particularly in vulnerable populations. The incorporation of observational research as part of clinical decision making is consistent with the position of many leading institutions. ASCO identified five overarching recommendations to enhance the role of observational research in clinical decision making: (1) improve the quality of electronic health data available for research, (2) improve interoperability and the exchange of electronic health information, (3) ensure the use of rigorous observational research methodologies, (4) promote transparent reporting of observational research studies, and (5) protect patient privacy.

UR - http://www.scopus.com/inward/record.url?scp=85022342472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022342472&partnerID=8YFLogxK

U2 - 10.1200/JCO.2017.72.6414

DO - 10.1200/JCO.2017.72.6414

M3 - Article

C2 - 28358653

AN - SCOPUS:85022342472

VL - 35

SP - 1845

EP - 1854

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 16

ER -